natgillin/translations-raw huggingface dataset:
It is of primary importance to initiate Kuvan treatment as early as possible to avoid the appearance of non-reversible clinical manifestations of neurological disorders in paediatric patients and cognitive deficits and psychiatric disorders in adults due to sustained elevations of blood phenylalanine.
Najbolj pomembno je, da se z zdravljenjem z zdravilom Kuvan začne čim prej, da se izognemo pojavu ireverzibilnih kliničnih manifestacij nevroloških motenj pri pediatričnih bolnikih in kognitivnega primanjkljaja ter psihičnih motenj pri odraslih zaradi dolgotrajno povišanih ravni fenilalanina v krvi.
It is of relevance to highlight that 19 of the 41 cases were prescribed overdose, with a median of 5 mg.
Pomembno je poudariti, da je bil v 19 od 41 primerov predpisan prevelik odmerek z mediano 5 mg.
It is okay if there are air bubbles.
Prisotnost mehurčkov je normalna.
It is okay if there are air bubbles.
Zračni mehurčki so lahko prisotni.
It is okay to see a drop of liquid on the tip of the needle.
Kapljica tekočine na konici igle je povsem običajna.
It is one of a family of medicines called COX-2 inhibitors (this is short for cyclo-oxygenase-2 inhibitors).
Gre za zdravilo iz skupine t. i. zaviralcev COX-2 (to je okrajšava za "zaviralci ciklooksigenaze
It is only for patients whose melanoma tumour cells have been shown to have a specific mutation (change) in the BRAF gene called ‘BRAF V600’.
Primerno je samo za bolnike, pri katerih je pri celicah melanoma dokazano prišlo do mutacije (spremembe) gena BRAF, imenovane BRAF V600.
It is only given on the first day of chemotherapy.
Uporablja se samo prvi dan kemoterapije.
It is only given on the first day of the chemotherapy and is followed by treatment involving a corticosteroid and a 5- HT3 antagonist.
Daje se samo prvi dan kemoterapije, čemur sledi zdravljenje, ki vsebuje kortikosteroide in antagoniste 5-HT3.
It is only used if the NSCLC is ‘ALK-positive’, which means that the cancer cells have certain defects affecting the gene responsible for a protein called ALK (anaplastic lymphoma kinase).
Uporablja se le, če je nedrobnocelični pljučni rak ALK-pozitiven, kar pomeni, da rakave celice vsebujejo določene okvare, ki vplivajo na gen, odgovoren za beljakovino, imenovano anaplastična limfomska kinaza (ALK).
It is only used in patients in whom collection of stem cells is difficult.
Uporablja se samo pri bolnikih, pri katerih je zbiranje matičnih celic težavno.
It is only used in patients where the virus has not developed resistance to a class of HIV medicines called non- nucleoside reverse transcriptase inhibitors, tenofovir or emtricitabine, and who have HIV levels in the blood (viral load) of no more than 100,000 HIV-1 RNA copies/ml.
Uporablja se samo pri bolnikih, pri katerih virus še ni razvil rezistence na razred zdravil za zdravljenje okužbe z virusom HIV, imenovanih nenukleozidni zaviralci reverzne transkriptaze (NNRTI), tenofovir ali emtricitabin, in pri katerih so ravni virusa HIV v krvi (virusna obremenitev) manjše od 100 000 HIV-1 RNA kopij/ml.
It is only used in patients who have been previously treated with other cancer medicines.
Uporablja se samo pri bolnikih, ki so se že zdravili z drugimi zdravili za zdravljenje raka.
It is only used in patients whose levels of HIV in the blood (viral loads) have been below 50 copies/ml for more than three months on their current HIV treatment combination.
Uporablja se samo pri bolnikih, pri katerih trenutna kombinacija zdravil za zdravljenje okužbe z virusom HIV več kot tri mesece vzdržuje ravni virusa HIV v krvi (virusno breme) pod 50 kopij/ml.
It is only used when the CML has already been treated with one or more tyrosine kinase inhibitors (medicines for CML which work in a similar way to Bosulif) and when the tyrosine kinase inhibitors called imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Uporablja se le, če je bil bolnik s kronično mieloično levkemijo že zdravljen z enim ali več zaviralci tirozinske kinaze (zdravili za zdravljenje te bolezni, ki delujejo podobno kot zdravilo Bosulif) in se zdravljenje z zaviralci tirozinske kinaze, imenovanimi imatinib, nilotinib in dasatinib, ne šteje za primerno možnost zdravljenja.
It is only used when the nail to fix the bone does not need ‘reaming’ (drilling to make room for nail placement).
Uporablja se samo, kadar za namestitev vijaka za pritrditev kosti ni potrebno vrtanje (vrtanje vijačne odprtine).
It is only used when the results of the test without a contrast agent are inconclusive.
Uporablja se samo takrat, kadar so rezultati preiskave brez kontrastnega sredstva nezanesljivi.
It is packaged in a foil laminate tray with a peelable foil lid.
Nahaja se v embalaži iz laminatne folije, zaprti s pokrovom.
It is particularly important that the medicine is not used in children under the age of 2 years (see section ‘Do not use SIMBRINZA’ above).
Še posebej je pomembno, da se zdravilo ne uporablja pri otrocih, mlajših od 2 let (glejte poglavje ‘Ne uporabljajte zdravila SIMBRINZA’ zgoraj).
It is particularly important that you mention any of the following medicines containing any of the following active substances, as your doctor may need to adjust the Jakavi dose for you.
Posebno pomembno je, da zdravniku poveste za naslednja zdravila, ki vsebujejo katero od naslednjih zdravilnih učinkovin, saj vam bo moral zdravnik morda prilagoditi odmerek zdravila Jakavi.
It is particularly important that you mention any of the following medicines:
Posebej pomembno je, da zdravniku poveste, če uporabljate katero od naslednjih zdravil:
It is particularly important to read the symptoms of a blood clot - see section 2 “Blood clots”.
Zlasti pomembno je, da preberete simptome krvnega strdka – glejte poglavje 2 "Krvni strdki").
It is particularly important to read the symptoms of a blood clot – see section 2 “Blood clots”).
Posebej pomembno je, da preberete simptome krvnega strdka - glejte poglavje 2 "Krvni strdki").
It is particularly important to tell your doctor if you are being treated with clopidogrel (an anti-platelet agent), warfarin (an anti-coagulant), or “non steroidal anti inflammatory drugs” for pain and fever (such as ibuprofen, naproxen, etoricoxib).
Še posebej je pomembno, da poveste svojemu zdravniku, če se zdravite s klopidogrelom (zdravilom proti trombocitom), varfarinom (antikoagulantom) ali “nesteroidnimi protivnetnimi zdravili” za bolečino in vročino (kot je ibuprofen, naproksen, etorikoksib).
It is particularly important to tell your doctor if you are using medicines that prevent blood from clotting (oral anticoagulants, e.g. warfarin).
Zlasti pomembno je, da zdravniku poveste, če jemljete zdravila za preprečevanje strjevanja krvi (peroralne antikoagulante, npr. varfarin).
It is particularly important to understand the information in section 3 before taking this medicine.
Zelo pomembno je, da pred začetkom jemanja tega zdravila razumete navodila v poglavju 3.
It is past the expiry date.
Rok uporabnosti je pretečen.
It is possible that Avastin can cause hypersensitivity and/or infusion reactions (reactions related to your injection of the medicine).
možno je, da lahko zdravilo Avastin povzroči preobčutljivost in/ali reakcije, povezane z infundiranjem (reakcije, povezane z injiciranjem zdravila).
It is possible that Avastin can increase the risk of bleeding in your lungs, including coughing or spitting blood.
možno je, da lahko zdravilo Avastin poveča tveganje za krvavitve v pljučih, vključno s kašljanjem in izpljuvanjem krvi.
It is possible that Avastin may cause bleeding in and around your brain.
možno je, da lahko zdravilo Avastin povzroči krvavitve v možganih in okoli možganov.
It is possible that Avastin may increase the risk of developing holes in the gut wall.
možno je, da lahko zdravilo Avastin poveča tveganje za pojav preluknjanja stene črevesja.
It is possible that no transfusions will be needed.
Mogoče transfuzije sploh ne bodo več potrebne.
It is possible that the risk of side effects affecting the muscles may be higher when any of these medicines (and some others that can affect muscles) is taken during treatment with Cubicin.
Možno je, da se bo pojavilo več neželenih učinkov na mišice, kadar ta zdravila (in še nekatera druga, ki vplivajo na mišice) jemljemo v času zdravljenja z zdravilom Cubicin.
It is possible that the systemic absorption from 27 mg chewable tablets may be higher than that from 60 mg hard capsules.
Mogoče je, da je sistemska absorpcija iz 27 mg žvečljive tablete večja kot iz 60 mg trdih kapsul.
It is possible to have a serious allergic reaction to LeukoScan.
Možno je, da na zdravilo LeukoScan odreagirate z resno alergijsko reakcijo.
It is possible to switch directly from oral administration to infusion and the other way around.
Možno je neposredno prehajanje iz peroralnega jemanja zdravila na infuzijo ter obratno.
It is postulated that these actions protect endothelial cells.
Domneva se, da te dejavnosti ščitijo endotelijske celice.
It is preferable not to take this medicine during pregnancy .
Priporočljivo je, da tega zdravila ne jemljejo nosečnice in matere, ki dojijo.
It is preferable not to take this medicine during pregnancy.
Priporočljivo je, da se tega zdravila v nosečnosti ne uporablja.
It is preferable not to take this medicine during pregnancy.
Priporočljivo je, da tega zdravila ne jemljejo nosečnice
It is preferable not to take this medicine during pregnancy.
Priporočljivo je, da tega zdravila ne jemljejo nosečnice in matere, ki dojijo.
It is preferable not to take this medicine during pregnancy.
Priporočljivo je, da tega zdravila ne jemljejo nosečnice.
It is preferable not to take this product during pregnancy.
Piporočljivo je, da se tega zdravila v nosečnosti ne uporablja.
It is preferable not to take this product during pregnancy.
Priporočljivo je, da se tega zdravila v nosečnosti ne uporablja.
It is preferable not to take this product during pregnancy..
Priporočljivo je, da tega zdravila ne jemljejo nosečnice in matere, ki dojijo.
It is preferable not to use this medicine during pregnancy.
Priporočljivo je, da tega zdravila v nosečnosti ne uporabljate.
It is preferable not to use this product during pregnancy and breast-feeding.
Priporočljivo je, da tega zdravila ne jemljejo nosečnice in matere, ki dojijo.
It is preferable to avoid the use of Cosentyx in pregnancy.
Najbolje je, da v času nosečnosti ne uporabljate zdravila Cosentyx.
It is preferable to avoid the use of Stelara in pregnancy.
Uporaba zdravila Stelara ni priporočljiva med nosečnostjo.
It is prepared from the highly purified virus-like particles (VLPs) of the major capsid L1 protein from the same four HPV types (6, 11, 16, 18) in qHPV vaccine Gardasil or Silgard and from 5 additional HPV types (31, 33, 45, 52, 58).
Pripravljeno je iz visoko prečiščenih virusu podobnih delcev (VLP – virus-like particles) velike plaščne (L1) beljakovine istih štirih tipov HPV (6, 11, 16 in 18) kot qHPV cepivi Gardasil ali Silgard in petih dodatnih tipov HPV (31, 33, 45, 52, 58).
It is presently not clear whether a higher dose of ribavirin (e.g.1000/1200 mg/day based on body weight) results in higher SVR rates than does the 800 mg/day, when treatment is shortened to 16 weeks.
1000/1200 mg na dan glede na telesno maso) povzroči višji delež trajnega virološkega odziva kot odmerek 800 mg na dan, kadar je zdravljenje skrajšano na 16 tednov.
It is printed on the labels and on the carton.
Natisnjen je na nalepkah in na škatli.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium into which a gene (DNA) has been introduced, which makes it able to produce anakinra.
Proizvaja se z metodo, imenovano „tehnologija rekombinantne DNK“, pri kateri se v bakterije vstavi gen (DNK), s katerim lahko te tvorijo anakinro.
It is produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce epoetin theta.
Proizvajajo ga z metodo, znano kot “tehnologija rekombinantne DNK”: izdela ga celica, ki je prejela gen (DNK), s katerim lahko tvori epoetin theta.
It is produced by a method known as ‘recombinant DNA technology’: the enzyme is made by cells into which a gene (DNA) has been introduced that makes them able to produce laronidase.
Proizvaja se z metodo, imenovano „tehnologija rekombinantne DNK“, pri kateri encim izdelajo celice, ki so prejele gen (DNK), kar jim omogoča tvorjenje laronidaze.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by a bacterium that has received a gene (DNA) that makes it able to produce it.
Proizvaja se z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri bakterija prejme gen (DNK), s katerim lahko tvori hormon.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by a bacterium which has received a gene (DNA) that makes it able to produce it.
Proizvaja se po metodi, imenovani „tehnologija rekombinantne DNA“: hormon tvori bakterija, ki je prejela gen (DNA), kar ji omogoča tvorjenje hormona.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by a yeast that has received a gene (DNA) that makes it able to produce somatropin.
Proizvaja se po metodi, imenovani “tehnologija rekombinantne DNK”: hormon tvori kvasovka, ki je prejela gen (DNK), ki ji omogoča tvorbo somatropina.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by bacteria into which a gene (DNA) has been introduced that makes them able to produce somatropin.
Proizvaja se z metodo, imenovano „tehnologija rekombinantne DNK“, pri kateri se v bakterijo vstavi gen (DNK), ki ji omogoča tvorbo somatropina.
It is produced by a method known as ‘recombinant DNA technology’: the hormone is made by yeast cells into which a gene (DNA) has been introduced that makes them able to produce it.
Proizvaja se z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri hormon izdelajo celice kvasovk, v katere so vstavili gen (DNK), s pomočjo katerega ga celice lahko tvorijo.
It is produced by recombinant DNA technology in Chinese hamster ovary (CHO) cells, and prepared without the addition of any human or animal derived protein in the cell culture process, purification or final formulation.
Pridobljen je s tehnologijo rekombinantne DNA v celicah jajčnika kitajskega hrčka (CHO – Chinese hamster ovary) in pripravljen brez dodajanja človeških ali živalskih proteinov v postopku celične kulture, prečiščevanja ali končne priprave.
It is produced by recombinant DNA technology in Chinese hamster ovary (CHO) cells, and prepared without the addition of any human – or animal derived protein in the cell culture process, purification or final formulation.
Pridobljen je s tehnologijo rekombinantne DNA v celicah jajčnika kitajskega hrčka (CHO – Chinese hamster ovary) in pripravljen brez dodajanja človeških ali živalskih proteinov v postopku celične kulture, prečiščevanja ali končne priprave.
It is provided in a 100 ml brown glass bottle with a white, child resistant screw cap.
Na voljo je v 100 ml rjavi steklenici z belo za otroke varno navojno zaporko.
It is provided in: a ready-to-use syringe, containing a single dose of 0.5 ml for injection;
Na voljo je v: pripravljeni injekcijski brizgi, ki vsebuje en odmerek 0,5 ml za injiciranje;
It is provided with a 1 ml pre-filled glass syringe of solvent for reconstitution (water for injections) and one needle.
Priložena je tudi napolnjena 1 ml steklena injekcijska brizga z vehiklom za rekonstitucijo (voda za injekcije) in ena igla.
It is prudent to reserve fluoroquinolones for the treatment of clinical conditions, which have responded poorly or are expected to respond poorly to other classes of antibiotics.
Pomembno je, da uporabimo fluorkinolone za zdravljenje takšnih kliničnih stanj, ki so slabo reagirala oz. predvidevamo, da bodo slabo odreagirala na zdravljenje z drugimi skupinami antibiotikov.
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Zato fluorokinolonskih pripravkov ne uporabljati za zdravljenje infekcij, kjer ni učinka ali pa je slabši od pričakovanega, ampak uporabite druge, ustrezne antibiotike.
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Zato fluorokinolonskih pripravkov ne uporabljati za zdravljenje infekcij, kjer ni učinka ali pa je slabši od pričakovanega, ampak uporabite druge, ustrezne antibiotike..
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Preudarno je prihraniti uporabo fluorokinolonov za zdravljenje kliničnih stanj, ki se slabo odzivajo ali za katera pričakujemo, da se bodo slabo odzivala na druge skupine antibiotikov.
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Preudarno je prihraniti uporabo fluorokinolonov za zdravljenje kliničnih stanj, ki se slabo odzivajo ali za katera pričakujemo, da so bodo slabo odzivala na druge skupine antibiotikov.
It is prudent to reserve third generation cephalosporins for the treatment of clinical conditions, which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials or first generation cephalosporins.
Priporočljivo je, da cefalosporine tretje generacije uporabite za zdravljenje kliničnih stanj, ki so slabo reagirala ali se pričakuje, da bodo slabo reagirala na ostale antibiotike ali prvo generacijo cefalosporinov.
It is quite normal to have a number of courses of Filgrastim ratiopharm treatment.
Povsem običajno je, da zdravljenje z zdravilom Filgrastim ratiopharm poteka v večih ciklih.
It is quite normal to have a number of courses of Ratiograstim treatment.
Povsem običajno je, da zdravljenje z zdravilom Ratiograstim poteka v večih ciklih.
It is quite normal to have a number of courses of Tevagrastim treatment.
Povsem običajno je, da zdravljenje z zdravilom Tevagrastim poteka v večih ciklih.
It is ready to use - you do not need to mix it with anything.
Cepivo je pripravljeno za uporabo – ni vam ga treba zmešati z ničemer.
It is recommended not to chew, crush or split the tablets because it may change the level of medicine in your body.
Tablet ni priporočljivo žvečiti, drobiti ali razpolavljati, saj lahko to spremeni koncentracijo zdravila v telesu.
It is recommended not to repeat ear cleaning until 21 days after the second administration of the product.
Čiščenja ušes ne ponovite, dokler ne mine 21 dni od druge aplikacije zdravila.
It is recommended that a 21-25 gauge needle be used when piercing the vial stopper for reconstitution and dilution.
Za prebadanje zamaška viale za rekonstitucijo in redčenje se priporoča uporaba injekcijske igle, velikosti 21- 25 G.
It is recommended that a fourth dose be given as a ‘booster’ at least six months after the third dose, preferably when the child is between 12 and 15 months of age.
Priporočeno je dati četrti odmerek kot „obnovitveni odmerek“ vsaj šest mesecev po tretjem odmerku, po možnosti med 12. in 15. mesecem otrokove starosti.
It is recommended that a fourth dose be given as a ‘booster’ at least six months after the third dose.
Četrti odmerek je priporočen kot obnovitveni odmerek vsaj šest mesecev po tretjem odmerku.
It is recommended that a healthcare professional trains patients in the proper technique for self-administering subcutaneous injections using the pre-filled pen.
Priporoča se, da zdravstveni delavec bolnika nauči pravilne tehnike za samoinjiciranje subkutane injekcije z uporabo napolnjenega injekcijskega peresnika.
It is recommended that a healthcare professional trains patients in the proper technique for self-administering subcutaneous injections using the pre-filled syringe.
Priporoča se, da zdravstveni delavec bolnika nauči pravilne tehnike za samoinjiciranje subkutane injekcije z uporabo napolnjene injekcijske brizge.
It is recommended that a standard 20 ml (non-automated) syringe be used to ensure that the exact amount (19.0 ml) of Water for Injections or of 9 mg/ml (0.9%) Sodium Chloride for Infusion is dispensed.
Priporočljiva je uporaba standardne 20-ml (neavtomatične) brizge, da se zagotovi aplikacija natančne količine (19,0 ml) vode za injekcije ali 9 mg/ml (0,9 %) natrijevega klorida za infundiranje.
It is recommended that a standard 20 ml (non-automated) syringe be used to ensure that the exact amount (19.0 ml) of water for injections or of sodium chloride 9 mg/ml (0.9%) solution for injection is dispensed.
Priporočljivo je, da uporabite standardno 20 ml (neavtomatsko) brizgo, da boste lahko zagotovili, da bo dodana natančna količina (19.0 ml) vode za injekcije ali 9 mg/ml (0.9%) raztopine natrijevega klorida za infundiranje.
It is recommended that a third dose be given as a ‘booster’ at least two months after the second dose, during the child’s second year of life.
Tretji odmerek je priporočen kot obnovitveni odmerek vsaj dva meseca po drugem odmerku v otrokovem drugem letu starosti.
It is recommended that a trough concentration be taken 1 or 2 weeks after switching formulations or tablet strength to confirm that the trough concentration is within the recommended target range.
Priporočljivo je odvzeti vzorec krvi za določanje najnižje koncentracije zdravila v stanju dinamičnega ravnovesja 1 teden ali 2 tedna po zamenjavi oblik zdravila ali jakosti tablet, da potrdimo, da je najnižja koncentracija v stanju dinamičnega ravnovesja v priporočenih tarčnih mejah.
It is recommended that agents which affect haemostasis should be discontinued prior to enoxaparin therapy unless their use is essential, such as: systemic salicylates, ASA, NSAIDs including ketorolac, dextran, and clopidogrel, systemic glucocorticoids, thrombolytics and anticoagulants, and other antiplatelet agents, including glycoprotein IIb/IIIa antagonists.
Pred začetkom zdravljenja z enoksaparinom je priporočljivo ukiniti zdravila, ki vplivajo na hemostazo, če ta niso nujna, npr.: sistemske salicilate, ASK, NSAID, vključno s ketorolakom, dekstran in klopidogrel, sistemske glukokortikoide, trombolitike in antikoagulante, druge antitrombotike, vključno z antagonisti glikoproteina IIb/IIIa.
It is recommended that agents which affect haemostasis should be discontinued prior to enoxaparin therapy unless their use is essential, such as: systemic salicylates, ASA, NSAIDs including ketorolac, dextran, and clopidogrel, systemic glucocorticoids, thrombolytics and anticoagulants, and other antiplatelet agents, including glycoprotein IIb/IIIa antagonists.
Pred začetkom zdravljenja z enoksaparinom je priporočljivo ukiniti zdravila, ki vplivajo na hemostazo, če ta niso nujna, npr.: sistemske salicilate, ASK, NSAID, vključno s ketorolakom, dekstranom in klopidogrelom, sistemske glukokortikoide, trombolitike in antikoagulante, druge antitrombotike, vključno z antagonisti glikoproteina IIb/IIIa.
It is recommended that Aivlosin is first mixed into 10 kg of the feeding stuff, followed by the rest of the feeding stuff and mixed well.
Aivlosin najprej vmešamo v 10 kg krme, temu dodamo ostalo količino krme, nato pa vse skupaj dobro premešamo.
It is recommended that Aivlosin is first mixed with 10 kg of the feeding stuff, followed by the rest of the feeding stuff and mixed well.
Aivlosin najprej vmešamo v 10 kg krme, temu dodamo ostalo količino krme in nato vse skupaj dobro premešamo.
It is recommended that all children who receive the first dose of Synflorix complete the full vaccination course.
Priporočljivo je, da se pri otrocih, ki dobijo prvi odmerek zdravila Synflorix, opravi celotno cepljenje.
It is recommended that all patients, be brought up to date with all immunisations in agreement with current immunisation guidelines prior to initiating RoActemra therapy.
Priporočljivo je, da se vsi bolniki cepijo v skladu z veljavnimi smernicami za cepljenje pred začetkom zdravljenja z zdravilom RoActemra.